JP2022501055A5 - - Google Patents
Info
- Publication number
- JP2022501055A5 JP2022501055A5 JP2021517046A JP2021517046A JP2022501055A5 JP 2022501055 A5 JP2022501055 A5 JP 2022501055A5 JP 2021517046 A JP2021517046 A JP 2021517046A JP 2021517046 A JP2021517046 A JP 2021517046A JP 2022501055 A5 JP2022501055 A5 JP 2022501055A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- expression vector
- conjugated
- pharmaceutical composition
- vector according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862736834P | 2018-09-26 | 2018-09-26 | |
| US62/736,834 | 2018-09-26 | ||
| US201862747646P | 2018-10-18 | 2018-10-18 | |
| US62/747,646 | 2018-10-18 | ||
| US201962805793P | 2019-02-14 | 2019-02-14 | |
| US62/805,793 | 2019-02-14 | ||
| PCT/US2019/053260 WO2020069194A1 (en) | 2018-09-26 | 2019-09-26 | Methods and compositions for treating a premature stop codon-mediated disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022501055A JP2022501055A (ja) | 2022-01-06 |
| JP2022501055A5 true JP2022501055A5 (cg-RX-API-DMAC7.html) | 2022-10-04 |
Family
ID=69949797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021517046A Pending JP2022501055A (ja) | 2018-09-26 | 2019-09-26 | 未成熟終止コドン媒介性障害を治療するための方法および組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US10905778B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3856253A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022501055A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019350869A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3114108A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020069194A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108603230A (zh) | 2015-10-09 | 2018-09-28 | 南安普敦大学 | 基因表达的调节与蛋白质表达失调的筛选 |
| CN116059236A (zh) | 2015-12-14 | 2023-05-05 | 冷泉港实验室 | 用于治疗常染色体显性精神发育迟滞5型和Dravet综合征的反义寡聚体 |
| KR20260009385A (ko) | 2017-08-25 | 2026-01-19 | 스톡 테라퓨틱스, 인크. | 병태 및 질환 치료용 안티센스 올리고머 |
| MX2020004587A (es) | 2017-11-02 | 2021-04-12 | Univ Iowa Res Found | Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt. |
| JP2021523227A (ja) | 2018-05-04 | 2021-09-02 | ストーク セラピューティクス,インク. | コレステリルエステル蓄積症の処置のための方法及び組成物 |
| KR20210134003A (ko) | 2019-02-27 | 2021-11-08 | 스톡 테라퓨틱스, 인크. | 병태 및 질환의 치료를 위한 안티센스 올리고머 |
| JP7712270B2 (ja) | 2019-11-01 | 2025-07-23 | テバード バイオサイエンシズ インコーポレイテッド | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
| BR112022020780A2 (pt) | 2020-04-14 | 2022-11-29 | Flagship Pioneering Innovations Vi Llc | Composições de trem e usos das mesmas |
| US12338437B2 (en) | 2020-05-11 | 2025-06-24 | Stoke Therapeutics, Inc. | OPA1 antisense oligomers for treatment of conditions and diseases |
| US20230203510A1 (en) * | 2020-05-29 | 2023-06-29 | Flagship Pioneering Innovations Vi, Llc | Trem compositions and methods relating thereto |
| WO2022118966A1 (ja) * | 2020-12-04 | 2022-06-09 | 国立大学法人京都大学 | 細胞内への核酸分子取り込み促進剤、医薬組成物、及び新規化合物 |
| EP4334450A4 (en) * | 2021-05-05 | 2025-06-18 | Tevard Biosciences, Inc. | Methods and compositions for treating a premature termination codon-mediated disorder |
| CA3235264A1 (en) * | 2021-10-13 | 2023-04-20 | Flagship Pioneering Innovations Vi, Llc | Trem compositions and methods of use |
| EP4202045A1 (en) * | 2021-12-22 | 2023-06-28 | Universität Hamburg | Synthetic transfer rna with modified nucleotides |
| EP4442826A1 (en) | 2023-04-06 | 2024-10-09 | Universität Hamburg | Synthetic dna construct encoding transfer rna |
| EP4458967A1 (en) | 2023-05-02 | 2024-11-06 | Universität Hamburg | Pharmaceutical composition comprising multiple suppressor transfer rnas |
| TW202521693A (zh) * | 2023-08-11 | 2025-06-01 | 大陸商上海科動生物技術有限公司 | 工程化抑制性tRNA分子和方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002508959A (ja) * | 1998-01-14 | 2002-03-26 | ヒューマン ジーン セラピー リサーチ インスティテュート | ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法 |
| WO2017049409A1 (en) * | 2015-09-25 | 2017-03-30 | The Centre For Drug Research And Development | Compositions for promoting readthrough of premature termination codons, and methods of using the same |
| CN107177592B (zh) * | 2016-03-10 | 2021-03-30 | 北京大学 | 抑制性tRNA通读提前终止密码子疾病中的截短蛋白 |
| PL3458074T3 (pl) * | 2016-05-16 | 2024-11-12 | Board Of Regents Of The University Of Texas System | KOMPOZYCJA DO DOSTARCZANIA tRNA W POSTACI NANOCZĄSTEK I SPOSOBY ICH STOSOWANIA |
| CN110612353A (zh) * | 2017-03-03 | 2019-12-24 | 加利福尼亚大学董事会 | 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向 |
| MX2020004587A (es) * | 2017-11-02 | 2021-04-12 | Univ Iowa Res Found | Métodos de rescate de codones de paro mediante reasignación genética con ace-arnt. |
-
2019
- 2019-09-26 WO PCT/US2019/053260 patent/WO2020069194A1/en not_active Ceased
- 2019-09-26 CA CA3114108A patent/CA3114108A1/en active Pending
- 2019-09-26 JP JP2021517046A patent/JP2022501055A/ja active Pending
- 2019-09-26 EP EP19868108.2A patent/EP3856253A4/en not_active Withdrawn
- 2019-09-26 AU AU2019350869A patent/AU2019350869A1/en not_active Abandoned
- 2019-10-28 US US16/665,526 patent/US10905778B2/en active Active
-
2021
- 2021-01-16 US US17/151,126 patent/US11617802B2/en active Active
-
2023
- 2023-04-03 US US18/130,278 patent/US20240050594A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2019060454A3 (en) | Adeno-associated virus variant capsids and methods of use thereof | |
| MX2020005451A (es) | Capsides variantes de virus adenoasociados y uso para inhibir la angiogenesis. | |
| WO2017189964A3 (en) | Compositions for the treatment of disease | |
| JP2003535043A5 (cg-RX-API-DMAC7.html) | ||
| JP2018520997A5 (cg-RX-API-DMAC7.html) | ||
| JP2018148890A5 (cg-RX-API-DMAC7.html) | ||
| WO2022098699A8 (en) | Compositions and methods for the treatment of tauopathy | |
| JP2019530462A5 (cg-RX-API-DMAC7.html) | ||
| WO2017197355A3 (en) | Adeno-associated virus variant capsids and methods of use thereof | |
| JP2012136541A5 (cg-RX-API-DMAC7.html) | ||
| RU2013119416A (ru) | Процесс получения поксвирусов и композиции поксвирусов | |
| MX2020000221A (es) | Secuencias de aminoacidos y de acidos nucleicos de adenovirus de grandes simios no humanos, vectores que contienen las mismas y usos de las mismas. | |
| JP2017113019A5 (cg-RX-API-DMAC7.html) | ||
| JP2016513115A5 (cg-RX-API-DMAC7.html) | ||
| JP2008534594A5 (cg-RX-API-DMAC7.html) | ||
| Rodríguez Stewart et al. | Enhanced killing of triple-negative breast cancer cells by reassortant reovirus and topoisomerase inhibitors | |
| WO2001089559A3 (en) | Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine | |
| JP2006506942A5 (cg-RX-API-DMAC7.html) | ||
| JP2005237328A5 (cg-RX-API-DMAC7.html) | ||
| JP2019531293A5 (cg-RX-API-DMAC7.html) | ||
| WO2020219766A8 (en) | Compositions useful in treatment of rett syndrome | |
| JP2006511212A5 (cg-RX-API-DMAC7.html) | ||
| JP2008508899A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2020071318A5 (cg-RX-API-DMAC7.html) | ||
| JP2005524719A5 (cg-RX-API-DMAC7.html) |